✦ LIBER ✦

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAPATINIB PLUS CAPECITABINE VERSUS CAPECITABINE ALONE IN THE SECOND LINE TREATMENT FOR BREAST CANCER TREATMENT

✍ Scribed by F Ejzykowicz; JW Hay

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN59 COST EFFECTIVENESS ANALYSIS OF LAP

✍ P. Anaya; F. Aldaco 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN113 PHARMACOECONOMIC ANALYSIS OF CAPE

✍ HH Chen; CS Chang; LT Chen; WT Chen; TC Hsu; JY Wang; CY Wen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE

✍ W Chen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Intravenous versus oral vinorelbine plus

✍ Vito Lorusso; Saverio Cinieri; Marianna Giampaglia; Mariangela Ciccarese; Andrea 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB

PCN35 A COST UTILITY ANALYSIS OF FULVEST

✍ M Pangali; A Christodoulopoulou; A Ardavanis; V Barbounis; E Galani; D Skarlos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB